Preview Company (Stock code) Event Presenter
Evgen Pharma - Headline Results of Phase II Trial of SFX-01 in Metastatic Breast Cancer
EVGEN PHARMA PLC (EVG) Evgen Pharma - Headline Results of Phase II Trial of SFX-01 in Metastatic Breast Cancer
EVGEN
Mon, 25 Mar 2019 09:00 am (UK time)
EVGEN